Regeneron to Acquire Bankrupt DNA Testing Company 23andMe for $256...
Regeneron Pharmaceuticals announced Monday that it will acquire DNA testing company 23andMe for $256 million through a bankruptcy auction. As part of the deal, Regeneron emphasized that it will adhere...